Mar 8, 2013 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Operations, Laboratory Pathology
Pathologists and clinical laboratory administrators should stay alert to the impact on the traditional role of pathology with increasingly effective, predictive clinical decision-support software To support the transition to predictive healthcare—and in a move that is a separate but parallel initiative to its Watson healthcare program—IBM (NYSE: IBM) recently unveiled its new healthcare analytics software. By mining structured and unstructured data, the software will enable physicians to more...
May 23, 2012 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Pathology
Goal of unique collaboration is to give physicians a more accurate way to diagnose and treat many types of cancer Two noteworthy healthcare organizations will collaborate with IBM (NYSE: IBM) to explore how IBM’s Watson can be used to help physicians deliver improved outcomes to patients. The collaboration involves one major health insurer and a prominent academic medical center in Los Angeles. WellPoint, Inc. (NYSE: WLP) will interact with oncology experts at the Cedars-Sinai Cancer Institute...
Apr 25, 2012 | Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
Clinical laboratory managers and pathologists have an opportunity to expand the presence of laboratory medicine IBM (NYSE: IBM) recently issued a press release announcing its new Watson Healthcare Advisory Board (WHAB). The board is comprised of healthcare leaders with a broad range of research, medical and business expertise. Unfortunately, that expertise does not include pathology or specialists in laboratory medicine. “Watson represents a technology breakthrough that can help...
Oct 20, 2010 | Laboratory News, Laboratory Pathology
Company will develop solutions for new reimbursement models, evidence-based care, and supporting health service delivery needs Earlier this fall, IBM Corporation (NYSE: IBM) announced plans to invest $100 million specifically to advance IBM capabilities in three key areas of healthcare informatics. That seemed like a big deal that might affect clinical pathology, since IBM is one of the information technology (IT) giants in the United States. However, Dark Daily editors made a surprising...
